Table 3.
Comparison of clinical and CSF characteristics in VPSV and VPSWOV patients within 1 week after the operation
| VPSV (n = 13) | VPSWOV (n = 10) | P 1 | P 2 | P | ||
|---|---|---|---|---|---|---|
| symptoms improved | headache | 10/11(90.1%) | 10/10(100%) | 0.001 | <0.001 | >0.999 |
| Visual | 4/7(57.1%) | 5/7(71.4%) | >0.999 | 0.153 | >0.999 | |
| Auditory | 1/2(50%) | 0/3 | 0.371 | 0.07 | 0.40 | |
| Mental change | 4/5(80%) | 2/3(66.7%) | 0.615 | 0.510 | 0.464 | |
| CSF | CSF pressure (mmH2O) median (range) | 153(55–330) | 180(95–330) | <0.001 | <0.001 | 0.402 |
| WBC count (×106/l) median (range) | 70(2–459) | 80(25–232) | 0.42 | 0.018 | 0.868 | |
| Protein, g/L median (range) | 1.43(0.3–7.7) | 1.61(0.51–3.98) | <0.001 | <0.001 | 0.334 | |
| Glucose(mmol/l) median (range) | 1.7(0.03–3.54) | 1.17(0.43–7.45) | 0.008 | 0.026 | 0.526 | |
| Chloride(mmol/l) median (range) | 117(103–126) | 116(103–126) | 0.285 | 0.020 | 0.96 | |
| India ink Cryptococcus count | 0(0–480) | 3.12E2(0–3.01E4) | 0.014 | 0.337 | 0.003 |
P1 pre-operation versus within 1 week post operation in the VPSV group
P2 pre-operation versus within 1 week post operation in the VPSWOV group
P VPSV versus VPSWOV within 1 week post operation